These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32015759)

  • 1. Acute myeloid leukemia with inv(16)(p13.1q22) and deletion of the 5'MYH11/3'CBFB gene fusion: a report of two cases and literature review.
    Lv L; Yu J; Qi Z
    Mol Cytogenet; 2020; 13():4. PubMed ID: 32015759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3'CBFB deletion in CBFB-rearranged acute myeloid leukemia retains morphological features associated with inv(16), but patients have higher risk of relapse and may require stem cell transplant.
    Tang G; Zou Y; Wang SA; Borthakur G; Toruner G; Hu S; Li S; Xu J; Medeiros LJ; Tang Z
    Ann Hematol; 2022 Apr; 101(4):847-854. PubMed ID: 35184217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute myeloid leukemia with inv(16) with CBFB-MYH11, 3'CBFB deletion, variant t(9;22) with BCR-ABL1, and del(7)(q22q32) in a pediatric patient: case report and literature review.
    Tirado CA; Valdez F; Klesse L; Karandikar NJ; Uddin N; Arbini A; Fustino N; Collins R; Patel S; Smart RL; Garcia R; Doolittle J; Chen W
    Cancer Genet Cytogenet; 2010 Jul; 200(1):54-9. PubMed ID: 20513535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inversion and deletion of 16q22 defined by array CGH, FISH, and RT-PCR in a patient with AML.
    Dawson AJ; Bal S; McTavish B; Tomiuk M; Schroedter I; Ahsanuddin AN; Seftel MD; Vallente R; Mai S; Cotter PD; Hovanes K; Gorre M; Gunn SR
    Cancer Genet; 2011 Jun; 204(6):344-7. PubMed ID: 21763633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of additional chromosomal abnormalities in adult acute myeloid leukemia with inv (16)/t(16;16)/CBFB::MYH11.
    Gao J; Santana-Santos L; Fu L; Alvey E; Chen Q; Wolniak K; Xia Z; Aqil B; Behdad A; Ji P; Sukhanova M; Abaza Y; Altman JK; Chen YH; Lu X
    Eur J Haematol; 2024 Jun; 112(6):964-974. PubMed ID: 38388794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Cytogenetic Characterization of a Structural Abnormal Chromosome 16 in a Patient with Acute Myeloid Leukemia Leading to Inversion Chromosome 16 with Concomitant 3'CBFB Deletion.
    Hurtado R; Guirales F; Wang A; Hamid B; Okabe A; Castro E; Tirado CA
    J Assoc Genet Technol; 2022; 48(1):17-23. PubMed ID: 35247255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Most Myeloid Neoplasms With Deletion of Chromosome 16q Are Distinct From Acute Myeloid Leukemia With Inv(16)(p13.1q22): A Bone Marrow Pathology Group Multicenter Study.
    Rogers HJ; Hsi ED; Tang G; Wang SA; Bueso-Ramos CE; Lubin D; Morrissette JJ; Bagg A; Cherukuri DP; George TI; Peterson L; Liu YC; Mathew S; Orazi A; Hasserjian RP
    Am J Clin Pathol; 2017 Apr; 147(4):411-419. PubMed ID: 28375434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of CBFB in a patient with acute myelomonocytic leukemia (AML M4Eo) and inversion 16.
    Egan N; O'Reilly J; Chipper L; Higgins M; Herrmann R; Cannell P
    Cancer Genet Cytogenet; 2004 Oct; 154(1):60-2. PubMed ID: 15381374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CBFB Break-Apart FISH Testing: An Analysis of 1629 AML Cases with a Focus on Atypical Findings and Their Implications in Clinical Diagnosis and Management.
    Yang RK; Toruner GA; Wang W; Fang H; Issa GC; Wang L; Quesada AE; Thakral B; Patel KP; Peng G; Liu S; Yin CC; Borthakur G; Tang Z; Wang SA; Miranda RN; Khoury JD; Medeiros LJ; Tang G
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inverted and deleted chromosome 16 with deletion of 3'CBFB identified by fluorescence in situ hybridization.
    Spencer DV; Cavalier M; Kalpatthi R; Quigley DI
    Cancer Genet Cytogenet; 2007 Nov; 179(1):82-4. PubMed ID: 17981221
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical and laboratory features of pediatric acute myeloid leukemia with inversion of chromosome 16].
    He YX; Xue YQ; Wang HY; Yang NC; Shao XJ; Xu J; Ji ZH; Huang YP; Ding YF; Hu SY
    Zhonghua Er Ke Za Zhi; 2012 Aug; 50(8):593-7. PubMed ID: 23158736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent acute myeloid leukemia with inv(16)(p13.1q22) and chronic lymphocytic leukemia: molecular evidence of two separate diseases.
    Lu CM; Murata-Collins JL; Wang E; Siddiqi I; Lawrence H
    Am J Hematol; 2006 Dec; 81(12):963-8. PubMed ID: 16917916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De Novo Acute Myeloid Leukemia with Combined
    Sethapati VR; Jabr R; Shune L; El Atrouni W; Gonzales PR; Cui W; Golem S
    Case Rep Hematol; 2020; 2020():8822670. PubMed ID: 33489389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of 16 p deletions by FISH in patients with inv(16) or t(16;16) and acute myeloid leukemia (AML).
    Martinet D; Mühlematter D; Leeman M; Parlier V; Hess U; Gmür J; Jotterand M
    Leukemia; 1997 Jul; 11(7):964-70. PubMed ID: 9204976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent molecular remission of refractory acute myeloid leukemia with inv(16)(p13.1q22) in an elderly patient induced by cytarabine ocfosfate hydrate.
    Arahata M; Shimizu Y; Asakura H; Nakao S
    J Hematol Oncol; 2015 Feb; 8():5. PubMed ID: 25652695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of an Additional Chromosome on the Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome-Positive Acute Myeloid Leukemia in Adults.
    Min GJ; Kim HJ; Yoon JH; Kwak DH; Park SS; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS
    Biol Blood Marrow Transplant; 2018 Aug; 24(8):1621-1628. PubMed ID: 29698793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of del(16)(q22) in a patient with acute myeloid leukemia with complex karyotype].
    Kim M; Lee JW; Lee JK; Hong YJ; Hong SI; Kang HJ; Cho EH; Chang YH
    Korean J Lab Med; 2010 Aug; 30(4):329-33. PubMed ID: 20805702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature.
    Quesnel B; Kantarjian H; Bjergaard JP; Brault P; Estey E; Lai JL; Tilly H; Stoppa AM; Archimbaud E; Harousseau JL
    J Clin Oncol; 1993 Dec; 11(12):2370-9. PubMed ID: 8246025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of CBFB/MYH11 transcripts in patients with inversion and other abnormalities of chromosome 16 at presentation and remission.
    Tobal K; Johnson PR; Saunders MJ; Harrison CJ; Liu Yin JA
    Br J Haematol; 1995 Sep; 91(1):104-8. PubMed ID: 7577615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and use of an antibody detecting the CBFbeta-SMMHC fusion protein in inv(16)/t(16;16)-associated acute myeloid leukemias.
    Viswanatha DS; Chen I; Liu PP; Slovak ML; Rankin C; Head DR; Willman CL
    Blood; 1998 Mar; 91(6):1882-90. PubMed ID: 9490670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.